- 专利标题： SUBSTANCE THAT INHIBITS P2Y12 RECEPTOR, FOR USE IN THE PREVENTIVE TREATMENT OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD'S PHENOMENON AND A DYSIMMUNITY
-
申请号： US16065932申请日： 2017-01-19
-
公开(公告)号： US20190015397A1公开(公告)日： 2019-01-17
- 发明人: Marie-Élise TRUCHETET , Cécile CONTIN-BORDES , Patrick BLANCO , Thierry SCHAEVERBEKE , Thomas BARNETCHE
- 申请人： UNIVERSITÉ DE BORDEAUX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX
- 优先权： EP16152005.1 20160120
- 国际申请： PCT/EP2017/051100 WO 20170119
- 主分类号： A61K31/4365
- IPC分类号： A61K31/4365 ; C07K16/28 ; A61P37/06
摘要：
Some embodiments are directed to a substance that inhibits P2Y12 receptor for use in the preventive treatment of systemic sclerosis in patients with Raynaud's phenomenon and a dysimmunity.
信息查询
IPC分类:
